# Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients

> **NCT00504452** · PHASE2 · TERMINATED · sponsor: **Koronis Pharmaceuticals.** · enrollment: 27 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** KP-1461

## Key facts

- **NCT ID:** NCT00504452
- **Lead sponsor:** Koronis Pharmaceuticals.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2008-09
- **Final completion:** 2009-06
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Corroboration of supporting in vitro data

\- Data successfully corroborated 2009
- **Last updated:** 2011-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00504452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00504452, "Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00504452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*